LifeSignals Receives US FDA Clearance To Market ECG Remote Monitoring Platform

 
• By Marion Webb

LifeSignals received 510(k) clearance for its Wireless Medical Biosensor LP1250, which can be integrated into third-party devices to remotely monitor patients for common cardiac arrythmias.

Heart beat icon

More from Approvals

More from Policy & Regulation